Khaitan Chemicals Q2FY27 standalone: PAT falls 44% YoY as margins compress
PAT -44.27% YoY · revenue -4.47% · margins compressing
₹294.82 Cr
-4.47% YoY
₹11.97 Cr
-44.27% YoY
4.06%
-2.9pp YoY
₹1.23
Khaitan Chemicals and Fertilizers reported standalone revenue from operations of ₹294.82 Cr for Q2 FY27 (quarter ended September 30, 2026), down 4.5% YoY from ₹308.61 Cr a year ago but up 33.4% QoQ from ₹220.94 Cr in Q1 FY27 — the sequential jump reflects fertiliser-segment seasonal buildup ahead of the Rabi season and should not be read as a trend reversal; YoY is the primary read here. Net profit fell 44.3% YoY to ₹11.97 Cr from ₹21.48 Cr, even as it rose 9.7% QoQ from ₹10.91 Cr. There were no exceptional items in either the current or year-ago quarter, so the YoY decline is on a clean, like-for-like basis. By segment, Fertilizers revenue fell 27.2% YoY to ₹197.48 Cr while segment profit held up comparatively better, down 6.3% YoY to ₹18.75 Cr; Chemicals & Speciality Chemicals revenue grew 50.7% YoY to ₹101.43 Cr but segment profit collapsed 60.5% YoY to ₹3.76 Cr — this segment is where the quarter's margin damage is concentrated.
Q2 FY-2027 vs prior quarters
Net profit margin compressed to 4.06% from 6.95% YoY and from 4.92% in Q1 FY27; operating margin (EBITDA/revenue) eased to roughly 8.7% from about 10.2% YoY and 10.67% in Q1 FY27. Finance costs rose 12.9% YoY to ₹9.03 Cr and depreciation rose 65.9% YoY to ₹3.22 Cr, both adding pressure below the operating line; current borrowings rose to ₹363.17 Cr from ₹277.75 Cr at FY26-end as inventories built up to ₹332.27 Cr from ₹223.44 Cr, consistent with the seasonal working-capital cycle. Khaitan Chemicals carries no formal guidance on record — none in our database, and a web search found none either — so this print cannot be graded against management's own targets; the company also has no analyst coverage on public trackers, so there is no street consensus to measure against. The Board approved these unaudited results on November 13, 2026 with an unmodified auditor review opinion; the company has no subsidiary, associate or joint venture, so the standalone statement is the complete and only basis for this filing.
The stock went into the print at ₹51.85, up 6.6% over the past month of trading.
For context: PAT has now risen for 2 consecutive quarters.
W1
Chemicals & Speciality Chemicals segment margin: profit fell to ₹3.76 Cr (-60.5% YoY) even as revenue rose 50.7% YoY to ₹101.43 Cr — whether this gap narrows next quarter
W2
Working-capital build: current borrowings at ₹363.17 Cr (from ₹277.75 Cr at FY26-end) funding inventories of ₹332.27 Cr — whether this unwinds as Rabi-season fertiliser sales materialize, and its effect on finance costs (+12.9% YoY)
W3
Fertilizers segment revenue down 27.2% YoY to ₹197.48 Cr — whether volumes recover in H2 FY27 (peak Rabi season)